米国における経カテーテル塞栓・閉塞装置市場：2007年

Abstract

The US transcatheter embolization and occlusion market was valued at over $340 million in 2006.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICE MARKET

• 1.1 Market Overview
  • 1.1.1 Transcatheter Embolization and Occlusion Device Overview
    • 1.1.1.1 Embolization Coils
    • 1.1.1.2 Interventional Neuroradiology Coiling-Assist Devices
    • 1.1.1.3 Embolization Particles
    • 1.1.1.4 Liquid Embolics
    • 1.1.1.5 Heart Defect Closure Devices
    • 1.1.1.6 Accessory Devices
• 1.2 Market Analysis
  • 1.2.1 Procedures
    • 1.2.1.1 Peripheral Vascular Procedures
    • 1.2.1.2 Interventional Neuroradiology Embolization Procedures
    • 1.2.1.3 Interventional Cardiology Procedures
  • 1.2.2 Market Forecast
    • 1.2.2.1 Embolization Coil Market
    • 1.2.2.2 INR Coiling-Assist Market
    • 1.2.2.3 Embolization Particle Market
    • 1.2.2.4 Liquid Embolic Market
    • 1.2.2.5 Heart Defect Closure Market
    • 1.2.2.6 Accessory Device Market
  • 1.2.3 Market Drivers and Limiters
• 1.3 Competitive Analysis

2.0 EMBOLIZATION COIL MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedures
    • 2.2.1.1 Interventional Neuroradiology Embolization Coil Procedures
    • 2.2.1.2 Peripheral Vascular Embolization Coil Procedures
  • 2.2.2 Market Forecast
    • 2.2.2.1 Interventional Neuroradiology Embolization Coil Market
    • 2.2.2.2 Peripheral Vascular Embolization Coil Market
  • 2.2.3 Market Drivers and Limiters
• 2.3 Competitive Analysis

3.0 INTERVENTIONAL NEURORADIOLOGY COILING-ASSIST DEVICE MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Procedures
  • 3.2.2 Market Forecast
  • 3.2.3 Market Drivers and Limiters
• 3.3 Competitive Analysis

4.0 EMBOLIZATION PARTICLE MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
    • 4.2.1.1 Polyvinyl Alcohol Particle Procedures
    • 4.2.1.2 Microsphere Procedures
    • 4.2.1.3 Selective Internal Radiation Therapy Procedures
    • 4.2.1.4 Drug-Eluting Bead Procedures
    • 4.2.1.5 Gelfoam Procedures
  • 4.2.2 Market Forecast
    • 4.2.2.1 Polyvinyl Alcohol Particle Market
    • 4.2.2.2 Microsphere Market
    • 4.2.2.3 Selective Internal Radiation Therapy Market
    • 4.2.2.4 Drug-Eluting Bead Market
    • 4.2.2.5 Gelfoam Market
  • 4.2.3 Market Drivers and Limiters
• 4.3 Competitive Analysis

5.0 LIQUID EMBOLIC MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Procedures
    • 5.2.1.1 Peripheral Vascular Liquid Embolic Procedures
    • 5.2.1.2 Interventional Neuroradiology Liquid Embolic Procedures
  • 5.2.2 Market Forecast
  • 5.2.3 Market Drivers and Limiters
• 5.3 Competitive Analysis

6.0 HEART DEFECT CLOSURE DEVICE MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Procedures
    • 6.2.1.1 Atrial Septal Defect Closure
    • 6.2.1.2 Patent Foramen Ovale Closure
    • 6.2.1.3 Ventricular Septal Defect Closure
    • 6.2.1.4 Patent Ductus Arteriosus Closure
  • 6.2.2 Market Forecast
    • 6.2.2.1 Atrial Septal Defect Closure Device Market
    • 6.2.2.2 Patent Foramen Ovale Closure Device Market
    • 6.2.2.3 Ventricle Septal Defect Closure Device Market
    • 6.2.2.4 Patent Ductus Arteriosus Closure Device Market
  • 6.2.3 Market Drivers and Limiters
• 6.3 Competitive Analysis

7.0 ACCESSORY DEVICE MARKET

• 7.1 Market Overview
• 7.2 Market Analysis
  • 7.2.1 Procedures
    • 7.2.1.1 Peripheral Vascular Transcatheter Embolization and Occlusion Accessory Devices
    • 7.2.1.2 Interventional Neuroradiology Transcatheter Embolization and Occlusion Accessory Devices
  • 7.2.2 Market Forecast
  • 7.2.3 Market Drivers and Limiters
• 7.3 Competitive Analysis

MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit ES-1: TEO Device Market, US (US$), 2005-2011
• Exhibit ES-2: TEO Device Market, by Device, as a % of Total, US, 2006
• Exhibit ES-3: TEO Embolization Coil Procedures, by Type, US, 2005-2011
• Exhibit ES-4: INR Coiling-Assist Market, by Device, as a % of Total, US, 2005-2011
• Exhibit ES-5: TEO Embolization Particle Market, by Device, US (US$), 2005-2011
• Exhibit ES-6: TEO Liquid Embolic Market, by Indication, US (US$), 2005-2011
• Exhibit ES-7: Heart Defect Closure Device Market, US (US$), 2005-2011
• Exhibit ES-8: TEO Accessory Device Market, by Indication, US (US$), 2005-2011
• Exhibit ES-9: Leading Competitors in the TEO Market, US, 2006

CHAPTER 1: US TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICE MARKET

• Exhibit 1-1: TEO Device Market, US (US$), 2005-2011
• Exhibit 1-2: TEO Procedures Covered, by Indication, US, 2006
• Exhibit 1-3: Embolization Coil Classification, US, 2006
• Exhibit 1-4: TEO Procedures, US, 2005-2011
• Exhibit 1-5: TEO Procedures, by Indication, US, 2005-2011
• Exhibit 1-6: TEO Procedures, by Indication, Type, and Device, as a % of Total,US, 2006
• Exhibit 1-7: PV TEO Procedures, by Type, US, 2005-2011
• Exhibit 1-8: PV TEO Procedures, by Device and Type, as a % of Total, US, 2006
• Exhibit 1-9: INR TEO Procedures, by Type, US, 2005-2011
• Exhibit 1-10: INR TEO Procedures, by Device and Type, as a % of Total, US, 2006
• Exhibit 1-11: IC TEO Procedures, by Type, US, 2005-2011
• Exhibit 1-12: TEO Market, by Indication, US (US$), 2005-2011
• Exhibit 1-13: TEO Market, by Device, US (US$), 2005-2011
• Exhibit 1-14: TEO Market, by Device, as a % of Total, US, 2005-2011
• Exhibit 1-15: Drivers of the TEO Device Market, US
• Exhibit 1-16: Limiters of the TEO Device Market, US
• Exhibit 1-17: Leading Competitors in the US TEO Device Market, by Device, 2006

CHAPTER 2: EMBOLIZATION COIL MARKET

• Exhibit 2-1: Embolization Coil Market, US, 2005-2011
• Exhibit 2-2: Embolization Coil Procedures, by Type, US, 2005-2011
• Exhibit 2-3: Embolization Coil Procedures, US, 2005-2011
• Exhibit 2-4: INR Embolization Coil Procedures, by Device Type, US, 2005-2011
• Exhibit 2-5: PV Embolization Coil Procedures, US, 2005-2011
• Exhibit 2-6: PV Embolization Coil Procedures, by Indication, as a % of Total, 2005-2011
• Exhibit 2-7: Embolization Coil Market, by Indication, US (US$), 2005-2011
• Exhibit 2-8: Embolization Coil Market, US (US$), 2005-2011
• Exhibit 2-9: INR Embolization Coil Market, by Type, US (US$), 2005-2011
• Exhibit 2-10: PV Embolization Coil Market, US (US$), 2005-2011
• Exhibit 2-11: Drivers of the INR Embolization Coil Market, US
• Exhibit 2-12: Limiters of the INR Coil Market, US
• Exhibit 2-13: Drivers of the PV Embolization Coil Market, US
• Exhibit 2-14: Limiters of the PV Embolization Coil Market, US
• Exhibit 2-15: Leading Competitors in the Embolization Coil Market, US, 2006

CHAPTER 3: INTERVENTIONAL NEURORADIOLOGY COILING-ASSIST DEVICE MARKET

• Exhibit 3-1: INR Coiling-Assist Market, US (US$), 2005-2011
• Exhibit 3-2: INR Coiling-Assist Procedures, by Device, US, 2005-2011
• Exhibit 3-3: INR Coiling-Assist Device Revenues, by Device, US (US$), 2005-2011
• Exhibit 3-4: INR Coiling-Assist Market, by Device, US (US$), 2005-2011
• Exhibit 3-5: INR Coiling-Assist Market Growth, by Device, US, 2005-2011
• Exhibit 3-6: Drivers of the INR Coiling-Assist Device Market, US
• Exhibit 3-7: Limiters of the INR Coiling-Assist Market, US
• Exhibit 3-8: Leading Competitors in the US Coiling-Assist Market, 2006

CHAPTER 4: EMBOLIZATION PARTICLE MARKET

• Exhibit 4-1: Embolization Particle Market, US (US$), 2005-2011
• Exhibit 4-2: Embolization Particle Procedures, by Device, US, 2005-2011
• Exhibit 4-3: Embolization Particle Procedure Growth, by Device, US, 2006-2011
• Exhibit 4-4: Embolization Particle Procedures, by Indication and Device, as a %of Total, 2005-2011
• Exhibit 4-5: Embolization Material Market, by Device, US (US$), 2005-2011
• Exhibit 4-6: Embolization Particle Market, by Device, US (US$), 2005-2011
• Exhibit 4-7: Embolization Particle Market Growth, by Device, US, 2006-2011
• Exhibit 4-8: Drivers of the Embolization Particle Market, US
• Exhibit 4-9: Limiters of the Embolization Particle Market, US
• Exhibit 4-10: Leading Competitors in the Embolization Particle Market, by Material, US, 2006

CHAPTER 5: LIQUID EMBOLIC MARKET

• Exhibit 5-1: Liquid Embolic Market, US (US$), 2005-2011
• Exhibit 5-2: Liquid Embolic Procedures, US, 2005-2011
• Exhibit 5-3: Liquid Embolics Procedures, by Indication, as a % of Total, US, 2005-2011
• Exhibit 5-4: Liquid Embolic Market, by Indication, US (US$), 2005-2011
• Exhibit 5-5: Liquid Embolic Market, US (US$), 2005-2011
• Exhibit 5-6: Drivers of the Liquid Embolics Market, US
• Exhibit 5-7: Limiters of the Liquid Embolics Market, US
• Exhibit 5-8: Leading Competitors in the US Liquid Embolics Market, 2006

CHAPTER 6: HEART DEFECT CLOSURE DEVICE MARKET

• Exhibit 6-1: Heart Defect Closure Device Market, US (US$), 2005-2011
• Exhibit 6-2: Heart Defect Closure Device Trials, RESPECT Trial
• Exhibit 6-3: Heart Defect Closure Device Trials, PREMIUM Trial
• Exhibit 6-4: Heart Defect Closure Device Trials, CLOSURE I
• Exhibit 6-5: Heart Defect Closure Device Trials, MIST II
• Exhibit 6-6: Heart Defect Closure Device Trials, ESCAPE Migraine Trial
• Exhibit 6-7: Heart Defect Closure Device Trials, CARDIA PFO Trial
• Exhibit 6-8: PFO Closure Device Market, No PMA Approval, US (US$), 2005-2011
• Exhibit 6-9: PFO Closure Device Market, PMA for Stroke Only, US (US$), 2005-2011
• Exhibit 6-10: PFO Closure Device Market, PMA for Stroke and Migraine with Aura, US (US$), 2005-2011
• Exhibit 6-11: Interventional Cardiologists, by Major City, US, 2005
• Exhibit 6-12: Physicians Performing PFO Diagnoses, by State, US, 2005
• Exhibit 6-13: Interventional Cardiologists and PFO Closure Interventional Cardiologists, by State, US, 2005
• Exhibit 6-14: Practicing Neurologists, by Major City, US, 2005
• Exhibit 6-15: Practicing Neurologists, by State, US, 2005
• Exhibit 6-16: Heart Defect Closure Procedures, US, 2005-2011
• Exhibit 6-17: Heart Defect Closure Device Market, as a % of Total, US, 2005-2011
• Exhibit 6-18: Heart Defect Closure Device Market, by Device, US (US$), 2005-2011
• Exhibit 6-19: Heart Defect Closure Device Market Growth, by Device, US, 2006-2011
• Exhibit 6-20: Heart Defect Closure Device Market, by Device, as a % of Total, US, 2006-2011
• Exhibit 6-21: Drivers of the Heart Defect Closure Device Market, US
• Exhibit 6-22: Limiters of the Heart Defect Closure Device Market, US
• Exhibit 6-23: Leading Competitors in the US Heart Defect Device Closure Market, 2006

CHAPTER 7: ACCESSORY DEVICE MARKET

• Exhibit 7-1: TEO Accessory Device Market, US (US$), 2005-2011
• Exhibit 7-2: TEO Accessory Device Procedures, by Indication, US, 2005-2011(Graphical Format)
• Exhibit 7-3: TEO Accessory Device Procedures, by Indication, US, 2005-2011(Tabular Format)
• Exhibit 7-4: PV Accessory Device Penetration, 2006
• Exhibit 7-5: PV Accessory Device Procedures, by Device, 2005-2011
• Exhibit 7-6: INR Accessory Device Units Used Per Procedure, by Procedure and Device, 2006
• Exhibit 7-7: INR Accessory Device Penetration, 2006
• Exhibit 7-8: INR Accessory Device Procedures, by Device, 2005-2011
• Exhibit 7-9: TEO Accessory Device Market, by Indication, US (US$), 2005-2011
• Exhibit 7-10: Total Accessory Device Market, by Indication, US (US$), 2005-2011
• Exhibit 7-11: PV Accessory Device Market, by Device, US (US$), 2005-2011
• Exhibit 7-12: PV Accessory Device Market Growth, by Device, US, 2006-2011
• Exhibit 7-13: INR Accessory Device Market, by Device, US (US$), 2005-2011
• Exhibit 7-14: INR Accessory Device Market Growth, by Device, US, 2006-2011 Exhibit 7-15: Drivers of the TEO Accessory Device Market, US
• Exhibit 7-16: Limiters of the TEO Accessory Device Market, US
• Exhibit 7-17: Leading Competitors in the US TEO Accessory Device Market, 2006